https://scholars.lib.ntu.edu.tw/handle/123456789/544255
標題: | Transurethral RollerLoop vapor resection of prostate for treatment of symptomatic benign prostatic hyperplasia: A 2-year follow-up study | 作者: | Liu C.-K. Lee W.-K. Ko M.-C. Jeng H.-S. Chiang H.-S. HONG-JENG YU |
關鍵字: | Benign prostatic hyperplasia; RollerLoop; Transurethral resection of prostate; Vapor resection | 公開日期: | 2006 | 卷: | 40 | 期: | 5 | 起(迄)頁: | 409-415 | 來源出版物: | Scandinavian Journal of Urology and Nephrology | 摘要: | Objective. We compared the 2-year safety and efficacy of two transurethral resection techniques-transurethral vapor resection of the prostate (TUVRP) and conventional loop transurethral resection of the prostate (TURP)-in the surgical management of benign prostatic hyperplasia. Material and methods. Between August 1997 and September 2002, 441 patients underwent transurethral prostatectomy, either TUVRP (n=221) or TURP (n=220). TUVRP was performed using a "RollerLoop" resection loop. All patients were assessed preoperatively by means of International Prostate Symptom Score (IPSS), quality of life (QOL) score, prostate volume, peak urinary flow (Qmax) and post-void residual volume (PVR) measurements and a sexual function questionnaire. Patients were followed up for 3, 6, 12 and 24 months after surgery, and this was followed by a comparison of the incidences of sexual dysfunction, complications and re-treatment. Results. After 2 years of follow-up, no differences were noted between the TUVRP and TURP groups with respect to average IPSS (p=0.9), QOL scores (p=0.56), Qmax (p=0.89) or PVR (p=0.55), as well as the incidences of bladder neck contracture or urethral stricture (p=0.34), re-treatment (p=0.49) or sexual dysfunction (p=0.57). However, significant reductions in operative time (p=0.005), decrease in serum hemoglobin levels (p<0.001), catheterization time (p<0.001), postoperative hospital stay (p<0.001) and hospitalization costs (p<0.001) were observed in the TUVRP group compared to the TURP group. Conclusion. Our results suggest that TUVRP provides equivalent safety and efficacy to TURP during a 2-year follow-up period, in which short-term advantages in perioperative morbidity and cost savings were also demonstrated. ? 2006 Taylor & Francis. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750290664&doi=10.1080%2f00365590600795222&partnerID=40&md5=6448d9a21c7ede8a7734da1a87c94077 https://scholars.lib.ntu.edu.tw/handle/123456789/544255 |
ISSN: | 0036-5599 | DOI: | 10.1080/00365590600795222 | SDG/關鍵字: | alpha adrenergic receptor blocking agent; hemoglobin; steroid 5alpha reductase inhibitor; adult; aged; article; bladder catheterization; bladder contraction; clinical effectiveness; controlled study; follow up; health care cost; hemoglobin blood level; hospitalization; human; intermethod comparison; major clinical study; male; micturition; morbidity; operation duration; outcome assessment; patient safety; postoperative complication; preoperative evaluation; priority journal; prostate hypertrophy; quality of life; questionnaire; reoperation; scoring system; sexual dysfunction; sexual function; transurethral resection; urethra stricture; urine flow rate; Aged; Electrodes; Electrosurgery; Follow-Up Studies; Hemostasis, Surgical; Humans; Male; Prostatic Hyperplasia; Reoperation; Sexual Dysfunction, Physiological; Transurethral Resection of Prostate; Volatilization |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。